Format

Send to

Choose Destination
Microb Pathog. 2013 Oct;63:19-23. doi: 10.1016/j.micpath.2013.05.014. Epub 2013 Jun 10.

Invasive African Salmonella Typhimurium induces bactericidal antibodies against O-antigens.

Author information

1
Novartis Vaccines Institute for Global Health, Via Fiorentina 1, 53100 Siena, Italy. simona.rondini@novartis.com

Abstract

Nontyphoidal Salmonella are a major and emerging cause of fatal invasive disease in Africa, and are genetically distinct from those found elsewhere in the world. Understanding the targets of protective immunity to these African Salmonellae is key to vaccine development. We immunized mice and rabbits with heat-inactivated wild-type African invasive Salmonella Typhimurium D23580 and rough mutants lacking O-antigen. Wild-type Salmonella, unlike rough bacteria, induced a large bactericidal antibody response mainly against O-antigen. Bactericidal ability of anti-O-antigen antibodies was confirmed following purification by affinity chromatography. The current findings support the development of an O-antigen conjugate vaccine against invasive nontyphoidal Salmonellae for Africa.

KEYWORDS:

Conjugate vaccine; NTS; Nontyphoidal Salmonella; O-antigen

PMID:
23756206
DOI:
10.1016/j.micpath.2013.05.014
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center